This study is looking at how an electronic health record (EHR) reminder affects prostate-specific antigen (PSA) screening rates for prostate cancer. The reminder encourages primary care providers to discuss PSA screening with eligible patients, but doesn't require it. The goal is to see if this reminder, along with tools for doctors, can help reduce late-stage prostate cancer without leading to too many unnecessary diagnoses. You might be able to join if you are a man between 40 and 75 years old, receive care within the BJC Health System, have had a primary care appointment recently, and meet certain risk criteria for prostate cancer, such as being African American or having a family history of the disease. The study aims to enroll 40,000 participants and is currently unclear on its recruitment status.

Study design

This is an interventional study, meaning it tests an intervention. It plans to include 40,000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will measure changes in PSA screening completion rates for up to 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.